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A physiologically based model of lead kinetics in children and adults has been developed and
tested. The premises on which the physiologically based model is founded are reviewed in this
paper. Because 95% or more of the body burden of lead in adults is found in the bone, bone
metabolism is central to the model. Bone volumes are expressed as functions of body weight.
Bone formation and resorption rates are estimated from human studies of stable labeled calcium
kinetics. Cortical and trabecular bone are modeled separately, with their surface-to-volume ratios
taken into account. Standardized growth curves are used to relate body weight to age. Other
model features such as organ volumes and physiologic functions are related to body weight based
on measurements made in human subjects over a range of ages. Calibrations of the model to two
human data sets are shown, and two applications to specific research questions are illustrated. A
brief comparison of the structure of this model with that of the Leggett model, and a comparison
of the output of this model with that of the integrated exposure uptake biokinetic model of the
U.S. Environmental Protection Agency, are also included. Environ Health Perspect 106(Suppl
6) 1495-1503 (1998). http://ehpnetl.niehs.nih.gov/docs/1998/Suppl-6/1495-1503oflaherty/
abstract.html
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A physiologically based model of lead
kinetics in children and adults has been
developed and tested. Several publications
detailing its development and applications
have appeared (1-3). The purposes ofthis
paper are to review the premises on which
the physiologically based model is built, to
outline its relationship to bone metabo-
lism, to depict some of its representations
of physiologic functions, and to illustrate
two of its applications. Brief comparisons
ofthis model with that ofLeggett (4) and
with the integrated exposure uptake bioki-
netic (IEUBK) model ofthe U.S. Environ-
mental Protection Agency (U.S. EPA) (5)
are also included.
Bone Physiology
and Metabolism
Total bone is conventionally considered to
be about 20% trabecular bone and 80%
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cortical bone (6,7). Although there actually
exists a spectrum of bone compositions
lying between prototypical cortical and
prototypical trabecular bone, the traditional
division into two bone types is a useful one
for modeling purposes.
Bone near the center oflong bones (the
diaphyseal region oflong bone) is typical
ofcortical bone. Figure 1 is a set ofschem-
atic drawings of growing and mature
cortical long bone in dogs, based on micro-
radiographs from Lee et al. (8). As the long
bone grows (Figure IA, B), its diameter is
enlarged by the deposition of concentric
lamellae at the outer (periosteal) surface
and the accompanying enlargement of its
marrow cavity by active bone resorption at
the inner (endosteal) surface. These proc-
esses are integral components ofthe model-
ing that shapes growing bone. Mature
diaphyseal bone, on the other hand (Figure
1C, D), no longer displays the ragged
endosteal surface that indicates active bone
resorption. Instead, mature cortical bone is
constantly renewed through the process of
remodeling, in which cavities are excavated
in existing bone by the action of osteo-
clasts. Each of these cavities is gradually
filled with new bone by the action of
osteoblasts. The open channel remaining
in the center, the haversian canal, carries a
blood vessel. The unit containing the
haversian canal and the surrounding bone
nourished by its blood vessel is an osteon.
Portions of two osteons are shown
enlarged in Figure 2. Formation of new
osteons appears to proceed without regard
for the boundaries of existing osteons.
Bone is laid down in the new osteon in
lamellae, beginning at the periphery and
moving in. Between the lamellae are cavi-
ties, or lacunae, which contain bone cells
called osteocytes. The osteocytes are nour-
ished via canalicules that radiate from each
lacuna, connecting the spaces between
lamellae with the haversian canal. These
canalicules are the smallest ofthe channels
that supply bone tissue with nutrients.
Bone in the interior of the vertebrae is
typical of trabecular bone (Figure 3).
Trabecular bone takes the form of narrow
plates and struts having a much greater
surface-to-volume ratio than cortical bone.
Mature trabecular bone displays little or
no osteonal remodeling activity. It is
renewed by surface remodeling, which
replaces and restructures it in response to a
variety of factors including physical
stresses. Loss of trabecular bone is largely
responsible for the fragility of vertebral
and hip bones in osteoporosis.
Table 1 gives an overview ofsome ofthe
important features ofbone physiology from
the standpoint ofdevising a model ofbone
metabolism. Surface-to-volume ratios in tra-
becular bone are 5 to 6 times those in corti-
cal bone, whereas cortical bone volume is 4
times that oftrabecular bone. These physi-
cal features ofbone appear to be reasonably
species independent. Ifbone remodeling
activity were assumed to be proportional to
total surface area, then from 55 to 60% of
total mature bone remodeling activity
would be assigned to trabecular bone.
Total mature bone remodeling activity,
however, is markedly species dependent.
Small animals like mice and rats, with rela-
tively short lifespans, display little cortical
bone remodeling activity as adults. Presum-
ably the need to replace aging cortical bone
in these species is less acute. Recent studies
in humans and in cynomolgus monkeys
suggest that bone turnover is comparable in
these two species. Although a range ofbone
turnover rates is found in both cortical and
trabecular bone, reflecting the range ofbone
structures as well as other regional differ-
ences, the ranges observed in the monkeys
(9,10) are consistent with experimental esti-
mates of total turnover in mature human
bone (Table 1).
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Lead and Calcium Metabolism
Bone turnover is usually expressed as the
mass ofcalcium exchanged per unit time.
Early histomorphometric studies linked
bone lead metabolism to that of calcium.
In 1933, in a series of experiments in
which the localization oflead in bone was
compared to that of calcium, it was
observed that
It was apparent that lead is always
deposited where mobilizable calcium
deposits are found. (11)
A C
B D
Figure 1. Transverse sections of femur midshaft from
a puppy (A,B) and a mature dog (C,D). Fully calcified
bone is white in these drawings; less fully calcified
bone is denoted by degrees of shading. Note in Figure
1D that as the new osteons are filled in by freshly
apposed bone mineral, the haversian canals that carry
the blood vessels become narrower. Because of the
general orientation of the haversian canals, most of
the channels are cut transversely, but some are cut
longitudinally. Drawings based on microradiographs
from Lee et al. (8).
The link was made more explicit by
other investigators.
After 11 days [offeeding lead to young
guinea pigs], lead deposits [in the diaph-
ysis ofthe femur]... consisted ofa broad
subperiosteal zone, a narrow subendosteal
zone, and broad zones around the vascu-
lar channels. [In addition,] . . . a fine
radiating structure was visible, especially
around distant lacunae. (12)
In long bones ofadult guinea pigs,....
the predominant deposit is now in the
subperiosteal lamellar region. Cortical
areas bordering on marrow space
contain little lead. Haversian and
Volkmann's canals are linedwith lead. .
Figure 2. Portions of two osteons. The older osteon
has been replaced in part by the younger one, which is
not yet fully filled in. Drawing based on photomicro-
graph from Alberts et al.(51).
. . Similarly, lead is present in bone cells
and bone canaliculi. (12)
The studies showed that lead was being
deposited on bone surfaces in general, and
on surfaces engaged in modeling and
remodeling in particular:
While in acute experimental lead poi-
soning lead is predominantly deposited
in the subperiosteal zone and in the
vicinity of the Haversian canals, the
localization ofnormal lead in humans is
strikingly different .... These patterns
[of "normal" lead deposition] are so
striking that the question oftheir origin
asserts itself. It is likely that the answer
is linked to bone remodeling. (13)
Figure 3. The structure of trabecular bone. A network
of connecting narrow plates and struts creates a bone
mesh with a high surface-to-volume ratio.
Table 1. Bone physiology and metabolism.
Total bone Cortical bone Trabecular bone References
Relatively species-independent characteristics
Volume fraction, % 100 80 20 (6,7)
Surface-to-volume ratio, cm2/cm3 40-50a 100250b (29-40)
Blood flow Proportional to bone formation rate Proportional to bone formation rate (41-43)
Species-dependent characteristics
Turnover rate of mature bone, %/year
Human 10 2-6 10-26 See belowc
Cynomolgus monkey 1-12 (100%/year, iliac crest) 30-50 (40%/year, iliac crest) (9,10)
Includes periosteal, endosteal, and haversian canal surfaces. bLower values generally associated with vertebral bone, higher values with iliac crest. ¶For total skeleton, see
references (42-49). For cortical and trabecular bone: encapsulation of literature data is found in Legett et al. (50).
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These early studies oflead distribution
in bone, associating it with surface deposi-
tion and incorporation into forming bone,
were more qualitative than quantitative. A
third mechanism of uptake of lead into
bone was defined more precisely in studies
with uranium and radium isotopes and
with isotopes of calcium itself. In one
experiment, 233U was administered to
young adult beagles and its distribution in
bone was evaluated between 1 and 726
days later. In cortical bone,
Initially uranium is seen on endosteal
and periosteal surfaces and lining the
Haversian canals. As a function oftime
postinjection, the intensity of the sur-
face label decreases and the cortical bone
volume acquires a diffuse, uniform
deposit. (14)
In trabecular bone,
Low magnification images show the
transition ofan initially heterogeneous
surface deposit at 1 day to a pattern in
which the dense deposits are diminished
as a function oftime in number but not
in intensity. Higher magniflcation
emphasizes the heterogeneous character
of the early deposits and a subsequent
gradual redistribution from surfaces to
bone volume. (14)
This redistribution of bone volume-
seeking elements, a group that includes
lead, throughout bone can be visualized as
a heteroionic exchange of the elements
with calcium (or an exchange of calcium
with calcium) within the bone crystal
matrix. Thus, surface exchange, deposition
with forming bone, and slow migration
throughout bone have all been implicated
as mechanisms by which lead can become
incorporated into bone.
Construction ofPhysiologically
Based Lead Kinetics Model
The physiologically based lead kinetic
model (hereafter called the O'Flaherty
model) has been developed as aseries oflev-
els. The model ofbone structure and age-
dependent metabolism was designed first,
then encapsulated by a model ofage-related
whole-body growth and metabolism. The
behavior of lead within this shifting
anatomic and physiologic framework was
added next. Finally, an exposure module
was constructed to try to capture the vari-
eties ofhuman lead exposure in as flexible a
form as possible. The parameters associated
with each ofthese levels were assignedvalues
based on the best appropriate data sets from
the relevant literature. In a few instances,
these data sets were from experimental
animals rather than humans, but human
data were relied on whenever possible.
Parameters assigned values at each level were
not allowed to change at the next or subse-
quent levels. With each model addition,
only the new parameters were examined and
assigned values.
The O'Flaherty model is based on body
weight. All tissue volumes and blood flow
rates, as well as bone turnover rates, are
linked to body weight by means ofexpres-
sions that reproduce physiologic measure-
ments. For example, Figure 4 illustrates the
volumes ofliver and kidney as functions of
body weight from birth to maturity (15).
The departure ofthe kidney weights from
linearity around 1 year ofage is probably
real but has not been explicitly modeled.
Figure 5 illustrates the body weight depen-
dence of the glomerular filtration rate
(15,16). These data, as shown, were fit
with two straight line segments. The
change in slope occurs around 1 year ofage,
when standard body weight is 11.7 kg,
which is also the age at which the deviation
of body weight dependence of kidney
weight from linearity is observed (Figure 4).
Some physiologic functions are different
in males and females even after body
weight has been taken into account. Figure
6 shows respiration rates for males and
females as functions of body weight from
birth to maturity (15). The data were fit
with straight line segments, a single one for
both males and females up to 1 year ofage
and separate line segments for males and
females subsequent to that age.
Bodyweight is defined by five constants,
two for the early childhood phase ofgrowth
and three for the subsequent adolescent
growth spurt and stabilization at mature
adult weight. Figure 7 shows bodyweight as
a function ofage for the white American
female. The five constants allow other
growth curves to be defined; for example,
growth curves for specific ethnic or cultural
groups or even for individuals. Once the
growth curve has been specified, the other
anatomic and physiologic features of the
model have been defined aswell.
Bone turnover is central to the model.
It is responsible for incorporation of lead
from blood plasma into forming bone and
for return of lead from bone to plasma as
bone is resorbed. Figure 8 shows bone
formation rate as a function of age. The
data are from a number ofcalcium isotope
uptake studies, which provide estimates of
the rates of new bone accretion. Bone
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Figure 4. The volumes of liver (A; left axis) and kid-
neys 1o; right axis) as functions of body weight in the
human. Data are from Johnson etal. (15). The lines are
the model simulations.
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Figure 5. Glomerular filtration rate as a function of
bodyweight. Data are from Johnson et al. (A)(15) and
Rubin et al. (o)(16). The line is the model simulation.
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Figure 6. Respiration rate in males (o) and females
(A) from birth to adulthood. Data are from Johnson
et al. (15). The lines are the model simulations.
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turnover is around 10% per year in the
adult, independent of gender. In the
model, 65% oftotal mature bone turnover
is assigned to trabecular bone and 35% to
cortical bone. Thus, mature trabecular
bone turnover in the model is (0.65 x
0.10/0.2)/year, or 32.5% per year. Mature
cortical bone turnover is (0.35x 0.10/0.8),
or between 4.3 and 4.4% per year. These
percentages are consistent with the histo-
morphometric bone turnover data from
adult cynomolgus monkeys (Table 1).
They are higher than the values of3% per
year for cortical bone and 18% per year for
trabecular bone based on strontium isotope
kinetics and used by the International
Commission on Radiological Protection
(ICRP) (4,17,18), which would give a
total bone turnover in adult humans of6%
per year.
Gender-specific differences in the age
dependence ofbone formation rate are to
be expected around puberty, which girls
generally experience earlier than boys.
However, there are too few data points,
particularly for girls, in this crucial age
range (Figure 8) to define gender-specific
curves on an empirical basis. The curves
shown are based on an arbitrary difference
modeled in the age at which the growth
rate begins to slow, set at 10 years for girls
and 11 years for boys. It is expected that
these cutoffvalues, as well as the maximum
rates ofnew bone accretion during adoles-
cence, may be revised as new information
about the timing and magnitude of the
changes in these very rapid rates ofbone
growth becomes available.
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Because total bone volume is defined as
a function ofbody weight, the expression
for bone formation rate can be combined
with the expression for net bone volume to
generate an expression for bone resorption
rate as a function of age or body weight.
The two expressions, for bone formation
rate and bone resorption rate, determine
the rates of incorporation of lead into
forming bone and loss oflead with resorb-
ing bone. In addition, lead is allowed to
diffuse into and throughout cortical bone
in the model. Mathematically, this diffu-
sion is expressed as a diffusion radially out-
ward from the canalicules. Diffusion is not
included in the trabecular bone compart-
ment. Because of the thinness of the tra-
beculae in human bone and in the bone of
smaller animals, haversian systems with
their constituent canalicules are not pre-
sent. The bone is supplied with nutrients
directly from the marrow space.
Running the model is straightforward.
The model includes exposure modules that
allow the user to design exposure scenarios
and to specify lead concentrations in air,
food, water, dust, and soil. The exposure
modules are similar to those in the U. S.
EPA's IEUBK model for children. An
important difference, however, is that back-
ground exposures in the O'Flaherty model
are date dependent, reflecting the marked
decreases in air and food lead that occurred
during the 1970s and 1980s. Exposures can
be changed during the course ofa simula-
tion run. Output concentrations in blood
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and tissues, including cortical and trabecular
bone, can be accessed and plotteddirectly or
imported into othergraphical orspreadsheet
software. The chieflimitation ofthe model
in its present form is that it is deterministic:
model output does not indude estimates of
population distributions.
Extensions of the model to accommo-
date pregnancy and to incorporate the loss
ofbone that occurs with aging are planned.
Model Calibration
Two fits ofthe model to human data are
illustrated in this section. It should be
emphasized these are data set fits, in which
parameters of the model were optimized
during the fitting process. One example is
for children, one for adults.
Figure 9 illustrates a model fit to one of
the longitudinal data sets from the
Cincinnati Prospective Lead Study (19).
The group of children whose blood lead
concentrations are shown here is the upper
quartile ofa large group that was followed
from birth for over 6 years. These data were
used to design the model expressions for soil
anddust ingestion rates, illustrated in Figure
10. Dust ingestion was assumed to begin
around age 3 months, to peak at age 2
years, and to fall off rather rapidly there-
after. Soil ingestion, an outdoor exposure,
was assumed to begin at around age 6
months, to peak at age 3 years, and then to
fall offfairly slowly with age as the child
presumably continues to play outdoors and
perhaps to participate in outdoor sports.
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Figure9. A model fit to the upperquartile ofchildren in
the Cincinnati Prospective Lead Study(19). The year of
birth was set at 1983 forthis simulation, drinking water
lead concentration at 0.005 mg/I, soil lead concentra-
tion at 4100 ppm (g/g), and dust lead concentration at
1200 ppm. These blood lead concentration data were
used to design the soil and dust ingestion curves shown
in Figure 10. The line is the resulting model simulation.
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Together, these two curves for soil and dust
ingestion generate the blood lead concen-
tration curve shown in Figure 9, which dis-
plays a rather sharp peak at age 2 years. The
maximum blood lead concentration at age
2 years was a consistent feature ofall quar-
tiles in the Cincinnati Prospective Lead
Study. It should be noted that lead uptake
from soil and dust is determined by both
age-dependent intake and age-dependent
fractional absorption from the gastrointesti-
nal tract. The curves illustrated in Figure 10
are coupled with a reasonable but some-
what uncertain expression, derived from an
incomplete database, for age-dependent
fractional lead absorption, which had been
calibrated prior to addition of the exposure
module to the model.
Figure 11 shows a simulation carried
out in the course ofgeneral model calibra-
tion (2), for a 50-year-old male with
workplace lead exposure superimposed on
ambient exposure. The curve is made up
of the end points of simulated 30-year
exposures to a range ofworkplace air lead
concentrations. The data points are from
a study by Van de Vyver et al. (20) in
which lead was assayed in ashed biopsy
samples from the iliac crest ofcontrol and
lead-exposed human subjects. As the
simulated relationship is for a 30-year
exposure, it would be expected to lie in
the upper range of the experimental data,
some of which would probably have rep-
resented shorter exposures. In addition,
the simulation displays a degree of curva-
ture that would not have been apparent
from examination of the data alone but
which nonetheless is entirely consistent
with them.
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Figure 10. The modeled soil and dust ingestion rates.
Together, these two curves generate the soil and dust
contribution to the blood lead concentration curve
shown in Figure 9.
Model Validation
Two examples ofmodel validation will be
given. These examples represent app-
lications of the model to specific lead
exposure issues without parameter adjust-
ments. In both these examples, application
of the model assisted in data resolution
and interpretation.
The first example uses an earlier model
version for the rat (21,22). One ofthe chief
uncertainties associated with lead modeling
is the wide range oflead bioavailability from
exogenous oral sources. Some of this vari-
ability is associated with the chemical and
physical nature of the source itself, and
some with the conditions under which
exposure occurs. For example, fractional
absorption is substantially greater in the fast-
ing state than in the fed state (23). A num-
ber of bioavailability studies have been
reported. In a standard experimental design,
animals are fed lead in the form ofconcern,
usually for about 30 days, after which the
concentrations oflead in blood, liver, kid-
ney, and bone are compared to those in ani-
mals given daily intravenous doses of a
soluble lead salt for 30 days. An estimate of
fractional lead absorption is obtained for
each tissue examined at each dose.
The physiologically based rat lead
kinetic model has been applied to one such
dataset (24). In this study (25), male and
female rats were fed for 30 days a diet for-
mulated with one of eight different lead
concentrations. The source of the lead was
two mine waste-containing soils, one with
5 times the lead concentration ofthe other.
An intravenous lead acetate group was
included (26). Bone, liver, and blood lead
concentrations were measured at the end of
20 40
Blood lead,ptg/di
Figure 11. Relationship between blood and bone lead
for a 50-year-old male with workplace lead exposure
superimposed on ambient exposure. Data are from
Van de Vyver et al. (20). The line is the model simula-
tion, made up of the end points of simulated 30-year
exposures to a range of different workplace air lead
concentrations.
the 30-day exposure period. The model
was fit to these data by optimizing the
absorption rate constant for each group of
rats at each dose level to achieve the best
simultaneous fit to blood, liver, and bone
lead concentrations. Thus, a single best
estimate of fractional bioavailability was
obtained from the three different tissue
concentration measurements at each dose
level (Table 2). (Note that tissue concen-
trations were judged to be indistinguish-
able from background concentrations at
several ofthe low dose levels.)
Table 2 also gives the estimates of
fractional bioavailability obtained by the
conventional calculation, in which tissue
concentrations were compared between
oral and intravenous dose groups. As can
be seen in the table, fractional bioavailabil-
ity estimates vary widely, are tissue depen-
dent, and display no apparent relationship
to dose level. In addition, a disadvantage of
this technique is that oral dose groups that
generate tissue concentrations outside the
range generated by intravenous dosing can-
not be used in the calculations. Figure 12
demonstrates that fractional bioavailability
estimated by application of the physiologi-
cally based model declines smoothly with
dose from a high of 1.6% at the lowest
dose to a low of0.24% at the highest dose.
Thus, the model integrates concentrations
in different tissues into a single best esti-
mate of fractional bioavailability at each
dose, and by doing so reveals a clear-cut
dose dependence of fractional bioavailabil-
ity that was not previously apparent. The
model can be applied at all dose rates at
which tissue concentrations are distin-
guishable from background concentrations.
In addition, because intravenous dose
groups are not used, reliance on the model
for estimation of fractional bioavailability
reduces the number ofanimals required in
a bioavailability study.
The second example application of the
physiologically based lead model uses
another version of the model. This version
has been developed for the cynomolgus
monkey, largely by scaling the human
model to the body weight of the monkey.
(The cynomolgus monkey skeleton is
lighter in proportion to body weight than
the human skeleton; actual data were used
to model the monkey skeleton as a function
ofbody weight in the scaled model.) This
model version was applied to the results of
a study in which adult female cynomolgus
monkeys were administered stable lead
isotopes sequentially, in order to label
body stores of lead (almost exclusively
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Table 2. Absolute percentage bioavailability of lead from test soils added to feed (study 1).
Percentage bioavailability: Percentage bioavailability: Percentage
Lead dose rate, blood concentrations bone concentrations bioavailability:
mg/kg/day for 30 days using standard method using standard method using PBK model
Soil in diet, % Lead in diet, ppm Males Females Males Females Males Females Males Females
0.2 1.62 (soil l) 0.124 0.150 1.31 (9.04)a 2.07 (7.75) 0.36(1.59) 0.39(1.58) b .b
0.5 4.05(soil l) 0.314 0.501 2.29(3.12) 5.72 (3.69) 0.48(0.64) 0.58(0.56) _b .b
0.2 7.82 (soil 1I1) 0.680 0.916 1.27(1.35) 2.23 (2.20) 0.087 (0.38) 0.36(0.36) 1.60 b
2 16.2 (soill) 1.20 1.88 2.18(0.82) 3.41 (1.23) 0.48(0.25) 0.43(0.18) 1.20 0.90
0.5 19.5(soil 1I1) 1.67 2.31 1.63(0.57) c 0.35(0.16) -C 0.95 0.85
5 40.5(soil I) 3.36 4.40 c -c c C 0.57 0.41
2 78.2 (soil 1I1) 5.42 7.63 -C -c c C 0.52 0.37
5 195 (soil 1I1) 12.7 23.8 -c c C -c 0.30 0.24
aStandard error in parentheses. bNotdistinguishable from background exposure. cThese calculations would have required extrapolation of intravenous dose concentration data.
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Figure 12. Percent absorption of lead from mine waste
test soil treatment groups as a function of lead intake
per unit bodyweight in male and female rats. Based on
Polak etal. (24).
bone lead) and thereby to distinguish
between blood lead originating from past
exposure and blood lead originating from
current (dietary) lead (27). An observation
made in this study was that on cessation of
controlled lead exposure at the end ofthe
isotope administration sequence, the blood
concentrations of those lead isotopes
administered earlier in the sequence, and
therefore representative ofendogenous lead,
exhibited a transient but distinct rise,
suggesting a shift to a new relationship
between bone lead and blood lead (Figure
13). The data shown in Figure 13 are for a
single isotope mixture enriched in 204Pb.
Administration of this isotope mix was
begun on day 0 ofthe study and terminated
on day 48. Lead exposure to other isotope
mixes continued at an unchanged rate until
exposure was terminated in this monkey on
day 619 of the study. After day 619, total
blood lead concentration, which is not
shown, fell sharply from 40 to 45 pg/dl to
15 to 20 pg/dl. As illustrated in Figure 13,
-200 0 200 400 600 800 1000
Day ofstudy
Figure 13. Concentration of a 204Pb-enriched lead iso-
tope mix in blood during the course of sequential
administration of a series of isotope mixes to an adult
female cynomolgus monkey. The line is the model
simulation. See textfor discussion.
the model predicts the observed rise in
endogenous blood lead at this time, with
subsequent continuation ofthe steady con-
centration decline at the rate observed
before cessation oflead exposure. This shift
in blood lead concentration does not repre-
sent a change in lead kinetics related to the
abrupt drop in exposure, as might be
inferred from the data alone. The model-
predicted shift is caused by the nonlinearity
ofthe relationship ofred cell lead to plasma
lead. Because lead is bound to a limited
number ofspecific sites in the red cell, the
capacity of the red cell to accommodate
lead is limited. Although plasma lead is lin-
early related to exposure, red cell lead (and
therefore blood lead) is not. At high blood
lead concentrations, a larger fraction of
total blood lead is present in the plasma
than at low blood lead concentrations.
Therefore, while plasma lead continues to
decline smoothly after cessation ofexposure
in the situation modeled in Figure 13, read-
justment of the equilibrium between
plasma and red cell lead as total blood
lead falls results in a shift in the plasma
lead-blood lead relationship to a higher
blood lead concentration for a given plasma
lead concentration.
Comparison with the
Leggett/ICRP Model
Another physiologically based lead kinetic
model has been developed and published
(4). It was presented and discussed at the
workshop at which this paper was also pre-
sented (28). The Leggett/ICRP model is
an expansion of an ICRP age-specific
model of lead metabolism (17,18). The
ICRP model distinguishes between bone
surface-seeking and bone volume-seeking
elements, ofwhich lead is bone volume-
seeking. The Leggett/ICRP model does
not include a diffusion mechanism for
movement of lead throughout the bone
volume. It accounts for the existence ofan
intermediate-term exchange process less
explicitly, by designating an exchangeable
bone volume and a nonexchangeable bone
volume. With time, some of the lead in
the exchangeable bone volume moves into
the nonexchangeable bone volume, where
it accumulates slowly and from which it
can be returned to plasma only by bone
resorption. The gradual transfer of lead
from exchangeable to nonexchangeable
pools accounts in the Leggett/ICRP model
for a gradual decrease in rate ofloss oflead
from the skeleton as time since exposure
increases. In sum, the Leggett/ICRP
model assigns the time dependence of
bone lead residence time to slow accumu-
lation of a nonexchangeable lead pool,
whereas the O'Flaherty model assigns the
time-dependence of bone lead residence
time to a gradual distancing of lead from
bone surfaces by diffusion throughout the
bone volume.
No exposure module is attached to the
Leggett/ICRP model. Otherwise, the
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Leggett/ICRP model isstructurally analogous
to the O'Flaherty model, although in a
number of respects the Leggett/ICRP
model is more complex. Exchanges between
a diffusible plasma compartment and
tissues except bone are considered to be
first order, but a nonlinear relationship
between plasma and red cell is included.
Tissue uptake and loss are defined in terms
of age-dependent transfer half-times,
which are assigned values by interpolation
between sequential ages for six different
age groups. The gastrointestinal tract is
modeled as four anatomically based seg-
ments, with absorption occurring only
from the small intestine and fractional
absorption being age-dependent stepwise
rather than continuously. Liver and kidney
both consist of two subcompartments.
Lead in blood interchanges among a
diffusible fraction, a plasma-bound frac-
tion, and the red cells. Plasma-bound lead
is not diffusible. With time, a gradual
age-dependent shift ofplasma-diffusible
lead to plasma-bound lead takes place.
Extravascular fluid is also a component of
the model. Excretion takes place not only
in urine and feces but also in sweat, hair,
skin, and nails. Most of these differences
between the two models are not critical to
model function, although the assignment
of different parameter values could cause
model outputs to be different for the same
set ofexposure conditions. The Leggett/
ICRP model has not been rigorously
tested against datasets other than those on
which it was based.
Comparison with the
U.S. EPA IEUBK Model
The IEUBK model developed by the
U.S. EPA is not physiologically based in
the sense in which either the Leggett/
ICRP model or the O'Flaherty model is.
Although compartments are identified
with tissues in the IEUBK model, it is pri-
marily a descriptive model designed to
reproduce blood lead concentrations in
children up to 7 years of age, in typical
urban exposure situations.
To compare the two models, the
O'Flaherty model was run for the U.S. EPA
lead exposure default conditions: out-
door air concentration 0.1 pg/m3 (the
O'Flaherty model does not distinguish
between outdoor and indoor air as the
IEUBK model does); drinking water
concentration, 4 pg/liter; soil and dust
concentrations, each 200 pg/g; dietary
uptake, age-dependent default daily rates;
and no contribution from paint. Because
ofthe different ways inwhich dietary expo-
sure data are entered in the two models
(the IEUBK model uses age-dependent
uptake rates in micrograms per day,
whereas the O'Flaherty model uses date
[year]-dependent intake rates and applies
an age-dependent fractional absorption to
them), the forms of the two curves for
uptake oflead from food and water cannot
be made congruent (Figure 14). Similarly,
because the same age-dependent fractional
absorption from the gastrointestinal tract is
applied in the O'Flaherty model to lead
originating from soil and dust, the curves
for uptake oflead from soil and dust do
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Figure 14. The rate of uptake of lead from food and
drinking water as a function of age in children. IEUBK
default values (points) and O'Flaherty model simulation
(curve), with intake of lead in food in the O'Flaherty
model designed to approximate as far as possible the
range of IEUBKdefaults.
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not have the same shape (Figure 15).
Uptake of lead from air behaves in the
same age-dependent fashion in the two
models. Although it is greater in the
O'Flaherty model than in the IEUBK
model (Figure 16), it is a very minor con-
tributor to blood lead overall under these
default conditions. Despite these quali-
tative and quantitative differences in lead
uptake, the two models give predicted
blood lead concentrations that are not
greatly dissimilar (Figure 17). This is not
unexpected, as both models were calibrated
against the same types of data for blood
lead concentrations in urban children. It is
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Figure 16. The rate of uptake of lead from air as a
function of age in children. IEUBK default values
(points) and O'Flaherty model simulation based on
the IEUBK default concentration of 0.1 pg/m3 (curve).
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Figure 15. The rate of uptake of lead from soil and
dust as a function of age in children. IEUBK default
values (points) and O'Flaherty model simulation based
on the IEUBK default concentration of 200 pg lead/g of
both dust and soil (curve).
Figure 17. Blood lead concentration as a function of
age in children. IEUBK model simulation (points)
and O'Flaherty model simulation (curve). Simulations
are based on the default uptake values illustrated in
Figures 14-16.
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an example ofhow highly parameterized
models can yield similar results in spite of
the assignment ofdifferent values to many
ofthe parameters.
Comment
Ideally, the calibration and validation of
any model should be entirely independent
of each other. The calibration step(s)
result in the assignment of values to the
parameters of the model, with greater or
lesser degrees of assurance depending on
the quality of the databases relied on.
Validation is the comparison of model
predictions for particular situations with
observations made under the same condi-
tions holding all parameter values con-
stant. Models designed to predict future
events may never be fully validated.
However, models such as these, which are
designed to predict the behavior of a
biological system or organism under a
specified set of conditions, are capable of
validation in that they can be shown to
perform well (or not well) under a variety
of different sets of conditions. If they do
not perform adequately, then recalibra-
tion or, depending on the nature of the
failure, model restructuring is in order. In
a sense, then, calibration and validation
are not entirely mutually independent
exercises for models of this kind. Each
process helps to inform the other. A vali-
dation failure may force model recalibra-
tion or redesign, whereas the process of
calibration may pinpoint areas of uncer-
tainty and suggest validation exercises
specifically designed to examine model
performance in these areas.
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